Kelly J W
Dermatology Unit, Alfred Hospital, Melbourne, Australia.
Arch Dermatol. 1992 May;128(5):657-60.
Management of lentigo maligna (Hutchinson's melanotic freckle, in situ lentigo maligna melanoma) by regular observation relies on the detection of invasive melanoma before it has developed significant life-threatening potential. Recent studies indicate that lentigo maligna melanoma does not have a better prognosis than other forms of melanoma.
A case is reported of an amelanotic lentigo maligna that evolved from a macular lesion to a deeply invasive, amelanotic, lentigo maligna melanoma within 6 months. The melanoma was Clark level IV and measured 3.0 mm in maximum tumor thickness.
Observation of lentigo maligna at 6-month intervals would not seem to be sufficiently reliable in detecting the development of invasive lentigo maligna melanoma before it becomes a life-threatening disease. Early surgical excision is the treatment of choice.
通过定期观察来管理恶性雀斑样痣(哈钦森黑素性雀斑,原位恶性雀斑样痣黑色素瘤),这依赖于在侵袭性黑色素瘤发展出显著的危及生命的潜能之前将其检测出来。最近的研究表明,恶性雀斑样痣黑色素瘤的预后并不比其他形式的黑色素瘤更好。
报告了1例无色素性恶性雀斑样痣病例,该病例在6个月内从黄斑病变演变为深度侵袭性、无色素性恶性雀斑样痣黑色素瘤。该黑色素瘤为克拉克IV级,最大肿瘤厚度为3.0毫米。
每隔6个月对恶性雀斑样痣进行观察,在检测侵袭性恶性雀斑样痣黑色素瘤发展成危及生命的疾病之前,似乎不够可靠。早期手术切除是首选治疗方法。